In addition to the measures referred to in Article 26, the Commission shall be empowered to lay down, where necessary, by means of implementing acts, measures to ensure the effective monitoring of trade between the Union and third countries in drug precursors, in particular with regard to the design and use of export and import authorisation forms, for the purpose of preventing the diversion of drug precursors. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 30(2).
Art. 28 Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monito…
Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 Novembe…Lawamends
Regulation (EU) 2015/101311Law
1. Разрешенията за износ и внос, посочени в член 28 от Регламент (ЕО) № 111/2005, се издават във формата, определен в приложения III и IV към …
Commission Implementing Regulation (EU) 2015/1013 of 25 June 2015 laying down rules in r…11Law
1. The export and import authorisations referred to in Article 28 of Regulation (EC) No 111/2005 shall have the format set out in Annex III or IV to this Regulation, respectively. By way of derogation from the first subparagraph, the box …
Changed on 30 Dec 2013
In addition to the implementing measures referred to in this RegulationArticle 26, the CommitteeCommission shall be empowered to lay down, where necessary, detailed rules by means of implementing acts, measures to ensure the effective monitoring of trade between the CommunityUnion and third countries in drug precursors , in particular with regard to the design and use of export and import authorisation forms, for the purpose of preventing the diversion of such substances, in particular with regard to the design and use of export and import authorisation formsdrug precursors. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 30(2).
- 30 Dec 2013 – todayin force
- 22 Dec 2004 – 30 Dec 2013earlier wording